Resources for patients
For help understanding clinical trial listings and for other resources, visit our Patient Resources section.
Non-small cell lung cancer clinical trials
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer accounting for 80% to 85% of all lung cancer cases.1
We are studying investigational medications across early-stage, locally advanced, and metastatic non-small cell lung cancer (NSCLC).
Non-small cell lung cancer (NSCLC) begins in the lining of the lungs and tends to develop and spread more slowly than small cell lung cancer. Through clinical trials, we are continuing our efforts to study investigational treatments for people with NSCLC.
There is a lot to consider when deciding whether to participate in a clinical trial. Any clinical trial includes risks, which the study doctor will review with you. Make sure you understand the risks before participating.
You can also call our clinical trial information center at 1-888-577-8839 to learn more.
If you’re not sure which area of focus you’re interested in, let our match tool guide you with just a few questions.
Explore non-small cell lung cancer clinical trials that are enrolling volunteers
Below is a list of all available non-small cell lung cancer clinical trials. You can narrow the results by choosing options in the dropdown menus below. You can
also sort results to show trials nearest to you by entering your city and state in the search field.
About clinical trials
Learn what clinical trials are, how they work, and if you may be eligible to participate.
Resources
- American Cancer Society. What Is Lung Cancer? American Cancer Society. Updated January 17, 2023. Accessed October 9, 2025. https://www.cancer.org/cancer/types/lung- cancer/about/what-is.html